Analogues of N-terminal truncated synthetic peptide fragments derived from RANTES inhibit HIV-1 infectivityRAMNARINE, Emabelle J; DEVICO, Anthony L; VIGIL-CRUZ, Sandra C et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 1, pp 93-95, issn 0960-894X, 3 p.Article

Synthesis, conformation, and immunogenicity of monosaccharide-centered multivalent HIV-1 gp41 peptides containing the sequence of DP178JIAHONG NI; POWELL, Robert; BASKAKOV, Ilia V et al.Bioorganic & medicinal chemistry. 2004, Vol 12, Num 12, pp 3141-3148, issn 0968-0896, 8 p.Article

Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and preventionLATINOVIC, Olga; LE, Nhut; REITZ, Marvin et al.AIDS (London). 2011, Vol 25, Num 9, pp 1232-1235, issn 0269-9370, 4 p.Article

Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposureSKURNICK, Joan H; PALUMBO, Paul; LLOYD, Joan et al.The Journal of infectious diseases. 2002, Vol 185, Num 4, pp 428-438, issn 0022-1899Article

Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea PigsKHATTAR, Sunil K; SAMAL, Sweety; DEVICO, Anthony L et al.Journal of virology. 2011, Vol 85, Num 20, pp 10529-10541, issn 0022-538X, 13 p.Article

Differential polarization of immune responses by co-administration of antigens with chemokinesFRAUENSCHUH, Achim; DEVICO, Anthony L; SIEW PHENG LIM et al.Vaccine. 2004, Vol 23, Num 4, pp 546-554, issn 0264-410X, 9 p.Article

Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5KISH-CATALONE, Tina M; WUYUAN LU; GALLO, Robert C et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1497-1509, issn 0066-4804, 13 p.Article

An Alteration of Human Immunodeficiency Virus gp41 Leads to Reduced CCR5 Dependence and CD4 IndependenceTAYLOR, Brian M; FOULKE, J. Scott; FLINKO, Robin et al.Journal of virology. 2008, Vol 82, Num 11, pp 5460-5471, issn 0022-538X, 12 p.Article

The role of chemokines in human immunodeficiency virus infectionGARZINO-DEMO, Alfredo; DEVICO, Anthony L; CONANT, Katherine E et al.Immunological reviews. 2000, Vol 177, pp 79-87, issn 0105-2896Article

Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by gag-env pseudovirion immunizationHAMMONDS, Jason; XUEMIN CHEN; FOUTS, Timothy et al.Journal of virology. 2005, Vol 79, Num 23, pp 14804-14814, issn 0022-538X, 11 p.Article

CCR5 density levels on primary CD4 T cells impact the replication and enfuvirtide susceptibility of R5 HIV-1HEREDIA, Alonso; GILLIAM, Bruce; DEVICO, Anthony et al.AIDS (London). 2007, Vol 21, Num 10, pp 1317-1322, issn 0269-9370, 6 p.Article

Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitroHEREDIA, Alonso; GILLIAM, Bruce; LATINOVIC, Olga et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, pp 2489-2496, issn 0066-4804, 8 p.Article

Rapamycin reduces CCR5 mRNA levels in macaques : potential applications in HIV-1 prevention and treatmentGILLIAM, Bruce L; HEREDIA, Alonso; DEVICO, Anthony et al.AIDS (London). 2007, Vol 21, Num 15, pp 2108-2110, issn 0269-9370, 3 p.Article

Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene FamilyBONSIGNORI, Mattia; POLLARA, Justin; MARSHALL, Dawn J et al.Journal of virology. 2012, Vol 86, Num 21, pp 11521-11532, issn 0022-538X, 12 p.Article

Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge modelKISH-CATALONE, Tina; PAL, Ranajit; PARRISH, John et al.AIDS research and human retroviruses. 2007, Vol 23, Num 1, pp 33-42, issn 0889-2229, 10 p.Article

Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapyMACHADO, Elizabeth S; LAMBERT, John S; TANURI, Amilcar et al.Journal of clinical virology. 2004, Vol 30, Num 1, pp 24-31, issn 1386-6532, 8 p.Article

Signature Biochemical Properties of Broadly Cross-Reactive HIV-1 Neutralizing Antibodies in Human PlasmaSAJADI, Mohammad M; LEWIS, George K; SEAMAN, Michael S et al.Journal of virology. 2012, Vol 86, Num 9, pp 5014-5025, issn 0022-538X, 12 p.Article

Mucosal and systemic HIV-1 Env-specific CD8⁺ T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vectorSHATA, Mohamed T; REITZ, Marvin S; DEVICO, Anthony L et al.Vaccine. 2001, Vol 20, Num 3-4, pp 623-629, issn 0264-410XArticle

Production of the HIV-suppressive chemokines CCL3/MIP-1α and CCL22/MDC is associated with more effective antiretroviral therapy in HIV-infected childrenLAMBERT, John S; MACHADO, Elizabeth S; DEVICO, Anthony L et al.The Pediatric infectious disease journal. 2007, Vol 26, Num 10, pp 935-944, issn 0891-3668, 10 p.Article

Identification and Characterization of an Immunogenic Hybrid Epitope Formed by both HIV gp120 and Human CD4 ProteinsLEWIS, George K; FOUTS, Timothy R; IBRAHIM, Sani et al.Journal of virology. 2011, Vol 85, Num 24, pp 13097-13104, issn 0022-538X, 8 p.Article

Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1DEVICO, Anthony L; FOUTS, Timothy R; SHATA, Mohamed T et al.Vaccine. 2002, Vol 20, Num 15, pp 1968-1974, issn 0264-410XConference Paper

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialHAYNES, Barton F; GILBERT, Peter B; LIAO, Hua-Xin et al.The New England journal of medicine. 2012, Vol 366, Num 14, pp 1275-1286, issn 0028-4793, 12 p.Article